Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06848894 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of Human Urinary Kallidinogenase for Acute Ischemic Stroke Patients Receiving Reperfusion Treatment

Study acronym: UNITE
StatusEnrolling by Invitation
PhaseNot applicable
Started2025-04-21
View on ClinicalTrials.gov ↗

Amendment history

2026-09-22
notable
Trial status changed: Recruiting → Enrolling by Invitation
2025-03-25
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start date2025-02→2025-03
Study sitesdetails revised at 1 of 1 site
2025-02-22
minor
Original filing
3,268 trials monitored
See 122 trials at risk
This study aims to explore the efficacy and safety of Human Urinary Kallidinogenase for acute ischemic stroke patients receiving intravenous thrombolysis and/or endovascular treatment.
Trial Details
NCT Number NCT06848894
Lead Sponsor Beijing Tiantan Hospital
Conditions Acute Ischemic Stroke
Enrollment 1,204 participants
Start Date 2025-04-21
Primary Completion 2026-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-09-21